Literature DB >> 2664753

Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

J P Uetrecht1.   

Abstract

Idiosyncratic drug reactions represent a poorly understood problem with serious medical implications. Many idiosyncratic drug reactions appear to be hypersensitivity reactions that involve an immune mechanism. The initiating step appears to involve the formation of a chemically reactive metabolite which can act as a hapten. Although the major site of drug metabolism is the liver, we have found that leukocytes, which contain myeloperoxidase and can generate hydrogen peroxide when stimulated, can also generate reactive metabolites. This has obvious implications for such idiosyncratic reactions as agranulocytosis. Furthermore, because of the importance of monocytes in the processing of antigen and the presentation of antigen to T lymphocytes in the initiation of an immunological reaction, formation of reactive metabolites by monocytes may also have implications for other idiosyncratic reactions such as drug-induced lupus and generalized idiosyncratic reactions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664753     DOI: 10.1023/a:1015934104984

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  75 in total

1.  Phenytoin hypersensitivity hepatitis and mononucleosis syndrome.

Authors:  M Brown; T Schubert
Journal:  J Clin Gastroenterol       Date:  1986-08       Impact factor: 3.062

2.  Assessment of polymorphonucleate leucocyte functions in adult epileptic patients undergoing long-term phenytoin treatment.

Authors:  G Ricevuti; M Marcoli; G Gatti; A Mazzone; S Lecchini; G M Frigo
Journal:  Hum Toxicol       Date:  1986-07

Review 3.  Metabolism of foreign compounds by gastrointestinal microorganisms.

Authors:  R R Scheline
Journal:  Pharmacol Rev       Date:  1973-12       Impact factor: 25.468

Review 4.  The immunologic and metabolic basis of drug hypersensitivities.

Authors:  L R Pohl; H Satoh; D D Christ; J G Kenna
Journal:  Annu Rev Pharmacol Toxicol       Date:  1988       Impact factor: 13.820

5.  In vitro inhibition of granulopoiesis by 4-amino-4'-hydroxylaminodiphenyl sulfone.

Authors:  R M Weetman; L A Boxer; M P Brown; N M Mantich; R L Baehner
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

6.  Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.

Authors:  B H Singsen; L Fishman; V Hanson
Journal:  Pediatrics       Date:  1976-04       Impact factor: 7.124

7.  Valproate-induced hepatic injury: analyses of 23 fatal cases.

Authors:  H J Zimmerman; K G Ishak
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

8.  Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine.

Authors:  S D Nelson; J R Mitchell; W R Snodgrass; J A Timbrell
Journal:  J Pharmacol Exp Ther       Date:  1978-09       Impact factor: 4.030

9.  Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.

Authors:  J Uetrecht; N Zahid; N H Shear; W D Biggar
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Idiosyncratic reactions to phenytoin.

Authors:  N G Powers; S H Carson
Journal:  Clin Pediatr (Phila)       Date:  1987-03       Impact factor: 1.168

View more
  15 in total

Review 1.  Hypersensitivity to pyrazolones.

Authors:  M Levy
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Dapsone Hypersensitivity Syndrome That Occurred during Treatment of Pediatric Patient with Erythema Elevatum Diutinum.

Authors:  Gun-Wook Kim; Hyun-Je Park; Hoon-Soo Kim; Su-Han Kim; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

3.  Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.

Authors:  M Pirmohamed; M D Coleman; F Hussain; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

Review 4.  Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; B K Park
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

5.  Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.

Authors:  Payal Bhaiya; Sanjoy Roychowdhury; Piyush M Vyas; Mark A Doll; David W Hein; Craig K Svensson
Journal:  Toxicol Appl Pharmacol       Date:  2006-04-17       Impact factor: 4.219

6.  Investigating the mechanisms of aromatic amine-induced protein free radical formation by quantitative structure-activity relationships: implications for drug-induced agranulocytosis.

Authors:  Arno G Siraki; Jinjie Jiang; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2010-05-17       Impact factor: 3.739

Review 7.  Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma.

Authors:  Nazife Gamze Usta; Cana Aksoy Poyraz; Melih Aktan; Alaattin Duran
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

Review 8.  Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.

Authors:  G J Kontoghiorghes
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 9.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 10.  Possible role of free radical formation in drug-induced agranulocytosis.

Authors:  R P Mason; V Fischer
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.